20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Sourcing High-Purity 112811-72-0: A Manufacturer's Perspective

For businesses in the pharmaceutical sector, sourcing critical chemical intermediates like 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid (CAS 112811-72-0) is a strategic imperative. As a dedicated manufacturer, our focus is on not just producing this compound, but producing it to the exacting standards required by the pharmaceutical industry. The journey from raw materials to a high-purity intermediate involves meticulous process control and rigorous analytical verification.

Our manufacturing facility in China is equipped with advanced synthesis and purification technologies. We understand that the end application – primarily the synthesis of Moxifloxacin – demands an extremely low impurity profile. Therefore, our production process for 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid is designed to minimize side reactions and effectively remove any unwanted byproducts. This commitment to quality control means that when you buy from us, you are investing in product integrity that directly impacts the safety and efficacy of the final drug product.

We consistently strive to offer competitive pricing without compromising on the quality that our clients, including many R&D scientists and procurement managers, have come to expect. This is achieved through optimized synthesis routes, efficient resource management, and economies of scale inherent in being a primary manufacturer. When looking for a supplier of CAS 112811-72-0, consider the manufacturer's expertise in quality assurance and their ability to provide consistent batch-to-batch quality. We aim to be that reliable partner, facilitating smoother operations and a more predictable supply chain for your pharmaceutical needs.

Engaging with a direct manufacturer like us can offer significant advantages, including better price negotiation and direct access to technical support regarding product specifications and application. We are proud to be a leading manufacturer and supplier of this key pharmaceutical intermediate, contributing to the global healthcare landscape by ensuring the availability of high-quality raw materials. We welcome inquiries from companies looking to establish a long-term, reliable sourcing relationship.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Role of Intermediates in Moxifloxacin Production

Next: Optimizing Moxifloxacin Synthesis: The Role of 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid

All Rights Reserved